Podcasts about AML

In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study supplemented by transcriptome and Mendelian randomization analyses to identify 28 loci and proteins associated with VTE recurrence risk. This work provides genomic evidence that inherited variants contribute to the risk of VTE recurrence, raising the possibility of a more personalized approach to the prevention of recurrent VTE. The study conducted by Dr. Schetelig and colleagues report the results of a long term trial on patients with poor-response AML, comparing outcomes between patients who received salvage chemotherapy versus immediate transplantation. With no difference in survival rates at 5 years, outcomes seem to be determined mainly by genetic risk factors, age, and comorbidities, therefore challenging the routine use of intensive remission induction before allogeneic transplant in patients with an available donor and underscore the need for novel therapeutic strategies for poor-risk AML.Featured Articles:Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial 

My interview with Vincent Chok, Founder and CEO of First Digital. In this episode of The Future of Money, we explore how stablecoins are evolving beyond crypto markets and into real-world payments. From AI agents making payments on our behalf, to the role of regulation, compliance, and emerging markets, this conversation looks at what the next 5 to 10 years of payments could actually look like. We discuss: - Where stablecoins are likely to see their biggest real-world use cases - How AI agents could automate payments without human involvement - The biggest bottlenecks holding back agent-to-agent payments today - Why compliance, AML, and identity matter even more in an AI-driven world - How stablecoins could unlock financial access in emerging markets - What going public means for legitimacy in the stablecoin industry - The future of yield, regulation, and the risks the crypto industry may be overlooking Powered  Powered by Phoenix Group The full interview is also available on my YouTube channel: YouTube: https://bit.ly/45oYZJl    

In dieser Folge begleitet uns ein realer Fall: Ein 48-jähriger Patient leidet über Wochen unter vielfältigen Entzündungszeichen. Doch die endgültige Diagnose einer akuten myeloischen Leukämie (AML) war nicht einfach zu stellen. PD Dr. Maximilian Christopeit erklärt, warum es so schwierig sein kann, eine AML frühzeitig zu diagnostizieren, wie sich eine AML pathophysiologisch entwickelt und wie die Überlebenschancen heutzutage sind.

BUSINESS: BSP backs tougher AML enforcement, bank secrecy reform to curb corruption | Dec. 31, 2025Subscribe to The Manila Times Channel - https://tmt.ph/YTSubscribeVisit our website at https://www.manilatimes.net Follow us: Facebook - https://tmt.ph/facebook Instagram - https://tmt.ph/instagram Twitter - https://tmt.ph/twitter DailyMotion - https://tmt.ph/dailymotion Subscribe to our Digital Edition - https://tmt.ph/digital Check out our Podcasts: Spotify - https://tmt.ph/spotify Apple Podcasts - https://tmt.ph/applepodcasts Amazon Music - https://tmt.ph/amazonmusic Deezer: https://tmt.ph/deezer Stitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes#KeepUpWithTheTimes Hosted on Acast. See acast.com/privacy for more information.

In this special year-end episode of This Week in AML, Elliot Berman and John Byrne look back at the first half of 2025—a period marked by sweeping changes and global challenges. From the surge in executive orders and controversial pardons in the U.S. to the EU's Digital Operational Resilience Act and FATF updates, the discussion covers key developments shaping compliance. They explore DOJ's shifting enforcement priorities, OCC's growing influence on crypto and banking charters, debates over the Corporate Transparency Act, and the rising costs of AML compliance. Plus, insights on human trafficking detection, cybersecurity threats, and the resurgence of check fraud. This is your comprehensive recap of a chaotic year in financial crime prevention.

In this episode, Jo and Zoe take a deep dive into what it really looks like to start a bookkeeping business in 2026. Rather than jumping straight into checklists and compliance, they challenge aspiring bookkeepers to step back and understand the real reason behind wanting to start a practice — freedom, financial stability, and flexibility. They explain how important it is to design the business around the lifestyle you want, not just the service you can offer. From choosing the right business structure to understanding insurance, personal finance boundaries, AML responsibilities, tech stacks, workflows, and pricing, the hosts walk through the updated fundamentals for 2026. They emphasise that building a practice that supports your wellbeing starts with clarity, boundaries, and intentional choices — not rushing into software subscriptions or under-charging. This episode acts as both a strategic reset and a practical roadmap for anyone wanting to launch confidently in the new year. ----------------------------------------------- About us We're Jo and Zoe and we help bookkeepers find clients, make more money and build profitable businesses they love. Find out about working with us in The Bookkeepers' Collective, at: 6figurebookkeeper.com/collective ----------------------------------------------- About our Sponsor This episode of The Bookkeepers' Podcast is sponsored by Xero. Get 90% off your first 6 months by visiting: https://xero5440.partnerlinks.io/6figurebookkeeper ----------------------------------------------- Promotion This video contains paid promotion. ----------------------------------------------- Disclaimer The information contained in The Bookkeepers' Podcast is provided for information purposes only. The contents of The Bookkeepers' Podcast is not intended to amount to advice and you should not rely on any of the contents of the Bookkeepers' Podcast. Professional advice should be obtained before taking or refraining from taking any action as a result of the contents of the Bookkeepers' Podcast. The 6 Figure Bookkeeper Ltd disclaims all liability and responsibility arising from any reliance placed on any of the contents of the Bookkeepers' Podcast.

In this week's episode, Blood editor Dr. James Griffin interviews authors Drs. Vincent Muczynski and Mark Geyer on their latest research published in Blood. Dr. Muczynski's research asks if there could there be a better gene than the factor VIII (FVIII) gene to transfer for curative treatment of hemophilia A? Dr. Geyer then explores CAR T cells armed with interleukin-18 (IL-18) secretion that target CD371, a transmembrane glycoprotein with high expression on AML and leukemia-initiating cells. Both studies explore finding novel targets for these powerful treatment modalities. Featured Articles:Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibodyCD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

Is compliance getting in the way of great estate agency? Simon King, non-executive director and industry thinker, unpacks how AML checks, material information updates and shifting guidance have created confusion and slowed transactions. He explains how the right partners and proptech can simplify processes, while reminding agents they can outsource the work, but not the responsibility.

In this heartfelt episode of Paige's Pod, Paige sits down with Laurie Roberts, founder of Larry Roberts Chicago, to talk about love, loss, creativity, and what it means to carry someone's legacy forward through art. Laurie shares the cinematic “meet cute” of how she met her late husband, Larry Roberts - an artist who created from deep emotion, using painting as therapy and self-expression. We talk about the vulnerable (and very real) difficulty of selling work that feels like a piece of your soul, and how Laurie supported Larry through the behind-the-scenes business side while he stayed rooted in the creative process. Laurie opens up about Larry's acute myeloid leukemia (AML) diagnosis in 2017, his final series of paintings, and the early days of grief - when everything went off the market and she didn't yet know what came next. That “next” became a powerful new chapter: transforming Larry's artwork into heirloom-quality, hand-knotted rugs, textiles, and home pieces - crafted with artisans in India and built to last for generations.Together, Paige and Laurie talk about:The beauty (and challenge) of being a multi-passionate creativeWhy art and color can shift mood, support healing, and bring joy to everyday spacesTaking risks in business, pivoting when needed, and the truth about “overnight success”How creativity can support people through hard seasons - especially illness, caregiving, and griefLaurie's advice for anyone wanting to honor a loved one's artistic legacy in a meaningful wayThis conversation is tender, inspiring, and full of permission to keep creating - even when life breaks your heart. Connect with Laurie + explore Larry's work:Website: LarryRobertsChicago.comSocial: @LarryRobertsChicago (Instagram / YouTube / Facebook)

We unpack why KYC in payments became so heavy and how to make it almost invisible with data orchestration, deep KYC, and thoughtful UX. NABU's approach prefills profiles from trusted sources, uses AI to verify the real world, and gives analysts clear, auditable evidence.• mission to move from onboarding to no boarding • why payments face extra AML and sanctions scrutiny • balancing seamless UX with regulatory obligations • EU AMLD6, UBO access, and national eID schemes • API orchestration across multi-country data sources • deep KYC using unstructured data and storefront checks • analyst-first design with explainable reports and flags • access and fairness gains when onboarding gets easierTo connect and keep up to date with all the latest, head over to www.jointheconnector.com or hit subscribe via your podcast streaming platformThank you for tuning into our podcast about global trends in the FinTech industry.Check out our podcast channel.Learn more about The Connector. Follow us on LinkedIn.CheersKoen Vanderhoydonkkoen.vanderhoydonk@jointheconnector.com#FinTech #RegTech #Scaleup #WealthTech

In this candid year-end conversation, John Byrne and Sarah Beth Felix dissect an unprecedented year in AML enforcement. Felix, President of Palmero Consulting and creator of "Dirty Money Weekly," describes what she sees as systematic dismantling of AML infrastructure despite stated priorities of combating fentanyl and transnational criminal organizations. With only four enforcement actions from traditional federal banking agencies compared to FINRA's 20+ penalties, the landscape has shifted dramatically. The discussion explores Treasury's proposal to give FinCEN veto authority over banking agency BSA decisions - a move Felix warns could create massive bottlenecks. They examine troubling patterns in recent OFAC sanctions penalties where entities disregard guidance while violations flow through traditional banks. Felix shares skepticism about AI replacing the "hyper suspicious" human judgment essential to AML work, noting AI tools consistently fail basic sanctions questions. The conversation addresses the stark gap between U.S. and European cryptocurrency regulation, with America applying 40-year-old money service business laws to digital assets while the EU has comprehensive frameworks like MiCA. Looking ahead to 2026, Felix urges AML officers to use reduced regulatory scrutiny strategically - eliminating legacy policies that waste time while remembering everything missed now can trigger future enforcement. She emphasizes focusing on cartels and foreign terrorist organizations, which now carry criminal liability for banking officers, and proactively auditing customer sanctions programs.

Dr. Eunice Wang joins host Rahul Banerjee, MD, for a clinician-focused discussion on AML, treatment complexity, and real-world leukemia management in today's evolving therapeutic landscape.

In this episode of This Week in AML, Elliot Berman and John Byrne unpack the latest developments in financial crime compliance. They discuss the U.S. Court of Appeals decision upholding the Corporate Transparency Act, new guidance from France's TracFin on detecting shell companies, and FATF's mutual evaluation of Belgium under its updated regime. The conversation also covers global civic space concerns, major enforcement actions in the U.S. and UK, IRS-CI's annual report highlights, and the OCC's conditional approval of crypto trust charters. Plus, breaking news on sanctions and fentanyl designations.

In 2025, regulatory changes and compliance are central to the finance sector. Regulatory technology (RegTech) is rapidly advancing, using AI and real-time monitoring to automate compliance tasks like KYC and AML, reduce costs, and improve accuracy. Key trends include predictive analytics, unified financial crime systems, and a shift toward risk-based frameworks, especially for digital assets. While automation streamlines operations and helps avoid fines, challenges remain with global regulatory differences, cybersecurity risks, and model errors. Innovations such as blockchain and cloud-based solutions are helping institutions adapt, and investing in RegTech is seen as essential for maintaining competitiveness and resilience in a fast-changing financial landscape.

In this episode, we speak with Synary Be, a resilient survivor of acute myeloid leukemia (AML), who shares her powerful journey of enduring three bone marrow transplants over eight years. Diagnosed suddenly in March 2017, Synary's story begins with a high fever that led to a shocking diagnosis: 93% leukemia. From that point on, her life transformed into a series of hospital stays, treatments, and moments that tested her strength and spirit.We learn how her first transplant involved two umbilical cord donors, one from the U.S. and another from Singapore. When that failed to graft, her younger brother flew from Australia to donate for her second transplant—a 50% match. After two years in remission, she relapsed again and required a third transplant, this time from her older brother, right in the midst of the COVID-19 pandemic. With travel restrictions in place, the donor cells had to be processed remotely and shipped to Stanford, showcasing the remarkable role of medical technology in saving lives.Despite being given only a 50% chance of survival for her third transplant, Synary put her trust in her doctors. Though she relapsed again, she now maintains remission through chemo pills. With no long-term data available for this new medication, she continues treatment cautiously and with optimism, trusting in the advancement of medicine.Synary spends some time opening up about the chronic graft-versus-host disease (GVHD) that followed her transplants. She explains its impact on her lungs, eyes, mouth, nails, and skin, detailing both the physical symptoms and the treatments that have helped her reclaim daily life. From scleral lenses to serum tears, to pulmonary rehab and steroid creams, she educates us on the challenges and management of GVHD.Beyond the physical toll, Synary discusses the mental health struggles tied to long-term illness—particularly anxiety from repeated hospitalizations. She emphasizes the importance of therapy, meditation, support groups, and the courage to seek help. Her words serve as a reminder that managing chronic illness includes caring for both mind and body.Synary's story wouldn't be complete without acknowledging her support system. Her husband, who acted as her full-time caregiver through 300 cumulative days of hospitalization, and her three children, endured major sacrifices. Friends and community support filled in the gaps, underscoring that no one should navigate transplant recovery alone.Even in the face of isolation, fatigue, and anxiety, Synary finds joy in simple pleasures: watching Christmas movies, going for walks, and spending time with family. Her message is clear—life is still good. And GVHD, while challenging, cannot take away her joy.Calm App — https://www.calm.comThanks to our Season 19 sponsors, Incyte and Sanofi.https://incyte.com/https://www.sanofi.com/en00:40 - Introduction to Synary Be01:20 - AML Diagnosis and First Transplant03:10 - Transplants and Donor Challenges04:06 - Relapses and Chemo Maintenance06:44 - Living with GVHD12:15 - GVHD Symptoms and Treatments13:40 - Support System and Caregiving15:34 - Isolation After Transplants16:38 - Mental Health & Anxiety19:03 - Coping and Finding Joy20:36 - Final Thoughts and Message of Hope National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, we sit down with Sue Stewart, a 36-year survivor of acute myeloid leukemia (AML) and the founder of BMT InfoNet. Sue walks us through her transplant journey, beginning with a difficult diagnosis in the late 1980s and the grueling induction chemotherapy that followed. With limited treatment options, she opted for an autologous bone marrow transplant—a relatively new and uncertain procedure at the time. Despite the intense side effects, including confusion and delusions, Sue recovered and slowly rebuilt her life. Her story is one of strength and long-term resilience, shaped by medical challenges and a determination to help others facing similar paths.After surviving her transplant, Sue felt driven to understand her experience and quickly saw the gap in patient-centered information. A high-profile court case involving bone marrow donation misinformation pushed her to act. In response, she started a small newsletter to provide reliable, understandable transplant information. What began with 700 names (pre-Internet) grew rapidly and became BMT InfoNet, an organization that now supports over 20,000 people weekly with resources, educational content, and peer support.We explore how GVHD care has transformed over the decades. Sue outlines progress in diagnostics, treatment options, and the move away from long-term steroid reliance. Her organization has helped shift the focus beyond survival to long-term quality of life, leading to the creation of survivorship clinics and a deeper understanding of transplant-related complications.Sue introduces us to BMT InfoNet's key programs, including Caring Connections, which matches patients and caregivers with peers based on similar experiences. We also learn about their online, professionally moderated support groups, offered to different patient communities. These groups have been instrumental in helping individuals process their experiences and stay connected.The organization's educational materials and annual survivorship symposium continue to empower patients to become active members of their care teams. Sue emphasizes the importance of recognizing symptoms early, understanding treatment options, and advocating for proper care—especially for GVHD, which many local doctors may not fully understand.Finally, Sue shares the story of how one patient's experience with ocular GVHD and scleral lenses led to a wider medical breakthrough. It's a powerful reminder of how patients can change the landscape of care by sharing their stories. BMT InfoNet's mission remains clear: provide support, share knowledge, and give voice to those on the transplant journey.BMT InfoNet: https://www.bmtinfonet.orgContact Email: help@bmtinfonet.orgThanks to our Season 19 sponsors, Incyte and Sanofi.https://incyte.com/https://www.sanofi.com/en00:40 - Introduction to Sue Stewart01:15 - Sue's AML Diagnosis and Transplant Story06:33 - Founding BMT InfoNet10:05 - Life Before the Internet: Lack of Resources12:43 - Progress in GVHD Treatment15:25 - Peer Support Through Caring Connections17:16 - Online Moderated Support Groups18:58 - Educational Resources on GVHD21:57 - GVHD Specialist Directory24:05 - Annual Survivorship Symposium26:17 - Financial Assistance for Patients27:39 - GVHD Wall of Hope and National GVHD Day30:01 - Final Story: How Patient Experience Changed GVHD Care National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, we talk with caregiver Sylvia Chunn of Nashville, who shares her journey alongside her husband David through his diagnosis of AML, a stem cell transplant, and the ongoing challenges of GVHD. Sylvia walks us through their intense timeline, from David's emergency diagnosis in January 2024 to his transplant in July and their extended stay in Atlanta, away from home and their teenage children, until February 2025. Her husband's transplant was successful in its purpose, but complications like heart failure and GVHD turned their lives upside down.We explore the caregiving experience through Sylvia's eyes, especially navigating chronic GVHD symptoms that affect David's gut, eyes, mouth, joints, and skin. She explains how their lives are now filled with medical appointments, medications, and managing side effects from treatment. Sylvia describes her role as a blend of cheerleader and drill sergeant, ensuring medications are taken and appointments kept, while also offering emotional support.Sylvia emphasizes the importance of self-care during the process. With limited financial flexibility, she found peace in simple things like reading through a Facebook book club, daily personal devotions, and leaning on her faith. Exercise helped at times, although maintaining consistency was difficult. She openly shares that she sought mental health support, including therapy and medication, to deal with stress, guilt, and isolation.The conversation turns to how this journey has affected intimacy and family dynamics. Sylvia candidly reflects on how medical realities changed their physical relationship but ultimately brought them emotionally closer. Time spent together—reading, reminiscing, and watching shows—became a new form of connection. They rediscovered old routines from their early marriage and built a stronger bond through shared trials.Sylvia also shares how their children, especially their youngest teenage twins and their adult daughter in medical school, responded to the crisis. She notes how her kids matured emotionally, became more empathetic, and stepped up in unexpected ways.We close with Sylvia offering heartfelt advice to other caregivers: keep showing up, stay grateful, and never forget the power of hope. She reminds us that while this journey is incredibly difficult, it's also filled with unexpected moments of closeness, resilience, and love.Thanks to our Season 19 sponsors, Incyte and Sanofi.https://incyte.com/https://www.sanofi.com/en00:40 - Introduction to Sylvia Chunn01:15 - David's AML Diagnosis and Transplant Decision02:10 - Living Away from Home for Treatment03:40 - Navigating Chronic GVHD05:30 - Caregiver Role and Daily Routine06:40 - Self-Care and Coping Strategies08:20 - Mental Health Support for Caregivers09:40 - Isolation and Infection Risks11:55 - Impact on Intimacy and Marriage16:20 - Parenting Through the Crisis18:40 - Reflections on Family Growth20:40 - Final Thoughts and Advice to Caregivers National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of AML Conversations, John Byrne discusses the evolving landscape of communication in the context of anti-money laundering (AML) and financial crime prevention with experts Justin Cole (First Pitch Communication) and Joe McNamara (AML RightSource). They explore the paradigm shift in how communication is integrated into investigations, the importance of legal considerations, the role of data verification, and the impact of investigative journalism. The conversation also delves into the ethical implications of using AI in communication and the future challenges facing the financial crime prevention space. Link to Justin's Article: https://www.amlintelligence.com/2025/10/insight-why-the-media-has-become-the-front-line-for-fighting...

In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspectives on the clinical implications of these data for patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML), including:Abstract 6: Phase II PARADIGM trial of azacitidine and venetoclax vs conventional intensive chemotherapy for fit patients with newly diagnosed AMLAbstract 47: Phase I/II SAVE trial of revumenib plus decitabine/cedazuridine and venetoclax in the cohort of patients with newly diagnosed AMLAbstract 766: Phase Ib KOMET-007 trial of ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-mutant AMLAbstract 654: Phase I/II VICEROY trial of venetoclax and azacitidine + gilteritinib in patients with newly diagnosed FLT3-mutated AML ineligible for intensive induction chemotherapyAbstract 903: 3-Yr Update of the phase II FASCINATION trial of asciminib and conventional BCR::ABL1 inhibitors in newly diagnosed CMLAbstract 906: Phase II ASC2ESCALATE trial of asciminib in patients with chronic-phase CML after 1 prior TKIPresenter:Amir T. Fathi, MDDirector, Leukemia ProgramMassachusetts General HospitalAssociate Professor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.Link to full program:https://bit.ly/48Ye45N Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Jonathan Schmalfeld and Jacob Robinson walk through the biggest crypto law and policy developments of the month of November. Jonathan is the Policy Director at The Digital Chamber, where he leads federal and state advocacy on digital asset regulation. Timestamps:➡️ 1:19 — Senate Agriculture Committee releases market structure draft➡️ 3:22 — Why DeFi and AML sections remain blank➡️ 3:52 — Chair Atkins' speech and push for taxonomy➡️ 6:32 — Treasury & IRS guidance on staking ETFs➡️ 10:39 — Uniswap's fee switch vote and winding down➡️ 13:53 — Coinbase reincorporates from Delaware to Texas➡️ 16:19 — MEV exploit trial ends in mistrial➡️ 23:36 — Samurai Wallet sentencing and liability risks➡️ 26:55 — DOJ's Tornado Cash filing and self-custody issues➡️ 30:29 — Digital Chamber launches State Network➡️ 33:37 — OCC guidance allowing banks pay gas fees➡️ 36:50 — What to watch next in GENIUS implementationSponsor: Day One Law, a boutique corporate law firm founded by Nick Pullman. Nick and his team at Day One provide strategic legal counsel to startups, crypto projects, and Web3 innovators. ⁠You can get in contact with them via this link⁠: ⁠⁠https://www.dayonelaw.xyz/#contact

At the 2025 American Society of Hematology Annual Meeting & Exposition (ASH), CancerNetwork® sat down with a variety of researchers and clinicians to discuss potential advancements across hematologic oncology care. These experts shared their findings related to investigational therapeutic regimens and strategies that may prove impactful across different multiple myeloma, lymphoma, and leukemia populations. First, Krina K. Patel, MD, MSc, highlighted findings from the phase 2 iMMagine-1 study (NCT05396885) assessing treatment with anitocabtagene autoleucel (anito-cel) among patients with relapsed/refractory multiple myeloma. According to Patel, an associate professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, the novel cellular therapy elicited an overall response rate (ORR) of 96% and a stringent complete response or CR rate of 74% among the evaluable patients. She also discussed how anito-cel's unique mechanism of action may show efficiency compared with other cellular therapy products while reducing the risk of cytokine release syndrome and other delayed toxicities. Next, Manali Kamdar, MD, spoke about data from a long-term follow-up phase 2/3 study (NCT03435796) based on the phase 3 TRANSFORM trial (NCT03575351) evaluating lisocabtagene maraleucel (liso-cel; Breyanzi) vs standard-of-care therapy for patients with relapsed/refractory large B-cell lymphoma (LBCL). Long-term follow-up showed that liso-cel continued to elicit improvements in progression-free survival and overall survival across this population. Kamdar, the clinical director of Lymphoma Services at the University of Colorado Anschutz School of Medicine, touched upon the patient subpopulations who are most suitable to receive liso-cel while emphasizing the agent's curative potential in the second-line setting. Finally, Wei Ying Jen, BM BCh, MA, MMed, MRCP, FRCPath, detailed results from the phase 1/2 SAVE trial (NCT05360160), which showed responses with an all-oral combination of revumenib (Revuforj), decitabine/cedazuridine (Inqovi), and venetoclax (Venclexta) for patients with newly diagnosed acute myeloid leukemia. Jen, an assistant professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, noted how an all-oral regimen may offer an “advantage” compared with standard intensive chemotherapy, which requires patients to travel to the hospital to undergo an infusion. References Patel K, Dhakal B, Kaur G, et al. Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: updated results from iMMagine-1. Blood. 2025;146(suppl 1):256. doi:10.1182/blood-2025-256 Kamdar M, Solomon S, Arnason J, et al. Lisocabtagene maraleucel (liso-cel) versus standard of care (SOC) for second-line relapsed or refractory large B-cell lymphoma (LBCL): First Results from long-term follow-up of TRANSFORM. Blood. 2025;146(suppl 1):3710. doi.10.1182/blood-2025-3710 Jen WY, DiNardo CD, Short NJ, et al. Phase II study of the all-oral combination of revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax (SAVE) in newly diagnosed AML. Blood. 2025;146(suppl 1):47. doi:10.1182/blood-2025-47

In this episode of This Week in AML, Elliot Berman and John Byrne dive into International Anti-Corruption Day and explore contrasting approaches to corruption and financial crime across the globe. From the UK's ambitious anti-corruption strategy and new FCA tools to the Basel AML Index findings, AUSTRAC's compliance updates, and EU fraud crackdowns, the discussion highlights global trends and challenges. The hosts also examine recent U.S. developments, including OCC guidance on crypto transactions and the newly released National Security Strategy, offering a perspective on what these changes mean for compliance professionals.

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance News. All, from the Compliance Podcast Network. Each day, we consider four stories from the business world, compliance, ethics, risk management, leadership, or general interest for the compliance professional. Top stories include: DOJ folds another set of corruption convictions. (ESPN) NY state drops cannabis corruption case. (NYT) Bessent wants DOT to take over all AML roles. (WSJ) Jack Smith opens a new law firm with other ex-DOJ officials. (Reuters) The Daily Compliance News has been honored as No. 2 in Best Regulatory Compliance Podcasts category. Learn more about your ad choices. Visit megaphone.fm/adchoices

As we approach 2026, compliance and learning teams face evolving challenges, from the Crime and Policing Bill to the complexities of AI and data protection. Ensuring your workforce is prepared for these changes goes beyond simple tick-box training—it's about driving meaningful behaviour and cultural shifts. In this episode, we bring you the recording of our live webinar, where VinciWorks' compliance experts Nick Henderson-Mayo and Ruth Mittelmann-Cohen, alongside Nelson Sivalingam, CEO and Co-Founder of HowNow, explore the future of compliance learning. Nelson shares his expertise on the latest trends in learning and development, focusing on how compliance training must evolve to stay ahead in 2026. Together, they discuss how L&D and compliance teams can collaborate to create lasting impact, from personalised learning paths to data-driven compliance strategies. In this recording, you'll hear about: • UK compliance learning priorities for 2026: From the Cyber Security and Resilience Bill to FCA non-financial misconduct rules • The future of compliance learning: Aligning training to business goals and driving long-term behavioural change • Data and AI governance: Training for the rollout of the Data (Use and Access) Act and EU proposals to reshape GDPR • Embedding compliance into everyday learning: The role of microlearning, nudges, and reinforcement • Global training trends: Managing Tranche 2 AML reforms in Australia, tariff evasion in the US, and training on sanctions risks in Russia and Syria This session is a must-listen for compliance managers, L&D professionals, and senior leaders who want to stay ahead of the curve in compliance training, helping to build a culture that not only meets regulatory requirements but also supports sustainable business success.

Oslo is the centre of global attention this week as the 2025 Nobel Peace Prize was presented, in absentia, to Maria Corina Machado – for her work promoting democratic rights in Venezuela.Venezuela is currently ranked as one of the most corrupt countries globally by Transparency International, struggling with widespread issues like money laundering, narco/terror financing, and international sanctions.In this episode, your Laundry hosts – Marit Rødevand, Fredrik Riiser, and Robin Lycka – are revealing: how financial crime is a threat to peace. The panel discuss: how the movement of dark money has real world consequences, how corruption erodes trust in governments, and whether compliance can lead to a safer world.Producer: Matthew Dunne-MilesEditor: Dominic Delargy____________________________________The Laundry podcast explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism.Tune in as we dissect headline news, unpack regulatory trends, and examine the real-world consequences of non-compliance — all through a uniquely compliance-focused lens.The Laundry is proudly produced by Strise.Get in touch at: laundry@strise.aiSubscribe to our newsletter, Fresh Laundry, here. Hosted on Acast. See acast.com/privacy for more information.

Episode 75: Cayman Directors with Darragh Murphy, Marfire Darragh Murphy from Marfire joins me in the Tokens of Wisdom Studio to tell us all about the wonderful world of Cayman fund directors. From choosing the right director, to working with them once chosen, to navigating the complexities across a fund's lifecycle, Darragh shares the wisdom.  Key Points From This Episode: What is the role of an independent director in the Cayman funds space? Does engaging an independent director mean I am losing control of my fund? Does my Cayman fund always need an independent director? How do you approach conflicts of interest in your role? What's your role in AML and KYC compliance? How do you handle situations when a fund is in distress?How should I choose the right director? What's the smartest thing a new fund manager can do?  Disclaimer: This show is for informational purposes only. Nothing presented here constitutes legal, investment or tax advice. The guests that join us share their considerable fund-related wisdom, but everything they share here is their personal opinion and for educational purposes only. On this show, they are speaking for themselves, and not for their employer or any affiliated entity. Tokens of Wisdom is produced by Dave Rothschild, partner at Cole-Frieman & Mallon LLP headquartered in San Francisco, California. For more information, visit https://colefrieman.com/ Links Mentioned in Today's Episode: Dave Rothschild - https://www.linkedin.com/in/davidcrothschild/Darragh Murphy - https://www.linkedin.com/in/darragh-murphy-cta/  Cole-Frieman & Mallon LLP - https://colefrieman.com/Marfire - https://www.marfire.co/   Music by Joe Ginsberg - https://www.instagram.com/thejoeginsbergFor any questions or comments, email: tow@colefrieman.com

Peter Van Valkenburgh is the Executive Director of Coin Center, a leading nonprofit research and advocacy group focused on cryptocurrency policy. In this episode, Peter joins The Bitcoin Frontier to explore why defending the right to self-custody is about much more than bitcoin — it's about the future of individual freedom, open-source innovation, and financial privacy. We dig into the parallels between the 1990s “crypto wars” and today's digital sovereignty battles, the threats facing developers of privacy tools, and the constitutional foundations for privacy and property in the digital age.SUPPORT THE PODCAST: → Subscribe → Leave a review → Share the show with your friends and family → Send us an email: podcast@unchained.com → Learn more about Unchained: https://unchained.com/?utm_source=you... → Book a free call with a bitcoin expert: https://unchained.com/consultation?ut...TIMESTAMPS:0:00 – Intro and Peter's journey from acting to bitcoin policy2:00 – Discovering the cypherpunks and the roots of internet freedom4:00 – Entering bitcoin through law school and meeting Jerry Brito6:00 – Founding Coin Center and defining “permissionless innovation”9:00 – The mission: protecting the freedom to build and use open blockchains11:00 – Bitcoin's privacy problem and the legal risks of building privacy tech13:00 – Educating DC: explaining bitcoin to Congress in the early days16:00 – Navigating the SEC, ICOs, and defining what counts as a security18:30 – The evolution from education to constitutional litigation22:00 – Bitcoin as the revival of a “bearer instrument” economy26:00 – The “secret right to cash” and the Fourth Amendment's blind spot30:00 – Privacy, property, and what bitcoin reveals about constitutional limits35:00 – The Keep Your Coins Act and why it matters for financial sovereignty43:00 – The DOJ's shift toward prosecuting developers — and why it's dangerous46:00 – Inside the Tornado Cash and Samurai Wallet prosecutions50:00 – How Coin Center is fighting for software publishing rights54:00 – Legislative progress: Clarity, Keep Your Coins, and BRCA1:00:00 – Lessons from the 1990s encryption wars1:03:00 – How liability protections shaped (and centralized) the internet1:08:00 – The convenience dilemma: why self-custody must become easier1:12:00 – The Bank Secrecy Act, mass surveillance, and new legal challenges1:19:00 – Coin Center's constitutional lawsuits for privacy and association rights1:23:00 – Why the BSA is ripe for reform — and bitcoin's role in that debate1:27:00 – Zero-knowledge proofs, AML, and a future of privacy-preserving compliance1:29:00 – How self-custody wallets enable digital identity and personal sovereignty1:31:00 – Closing thoughts: bitcoin as the foundation for a freer digital futureWHERE TO FOLLOW US: → Unchained X: https://x.com/unchained → Unchained LinkedIn:   / unchainedcom  → Unchained Newsletter: https://unchained.com/newsletter → Joe Kelly's Twitter: https://x.com/josephkelly → Peter Van Valkenburgh's Twitter: https://x.com/valkenburgh 

All works contained in this podcast are not intended to constitute legal or professional advice and may not reflect the views and opinions of CPA Australia. CPA Australia does not warrant or make representations as to the accuracy, completeness, suitability or fitness for purpose of this podcast and disclaims all liability and responsibility for any acts or omissions made in reliance of this podcast. Individuals should seek their own independent legal, financial or other advice for their specific circumstances. When anti-money laundering (AML) comes to mind, most accountants assume it only applies to large transactions – but that's now changing.  This episode explains new AML obligations for accountants. Specifically, how the reforms to AML and counter terrorism financing (CTF) in 2026 will affect many accounting practices.  You'll gain a clear understanding of what the changes will mean, including which services fall under the new designated services rules, how the regulator AUSTRAC (Australian Transaction Reports and Analysis Centre) will assess compliance and what firms can do now to prepare.  Key learnings include:  An explanation of the regulator AUSTRAC's role and tranche two reforms to the AML/CTF regime  The timeline for implementation of these new reforms  How to identify whether your services qualify as "designated" services  How to conduct risk assessments  Why client onboarding and beneficial ownership checks will become more detailed  What sole practitioners should consider in meeting new compliance obligations  Tune in now for valuable information on this key reform in 2026.    Host: Neville Birthisel, Advisor, Regulations and Standards, CPA Australia  Guest: Adrian Verdnik, Partner and Section Leader, Banking and Financial Services Practice, Hall & Wilcox. His financial services law practice covers superannuation, managed funds, insurance and financial advice.  Learn more about today's episode guest at the Hall & Wilcox website.  AUSTRAC's site has more information on what accountants need to know about AML and CTF reform.  Additionally, CPA Australia's Public Practice My Firm My Future site has further information on AML and CTF obligations for many practitioners in Australia.  Loving this episode?  Listen to more With Interest episodes and other CPA Australia podcasts on YouTube.  CPA Australia publishes four podcasts, providing commentary and thought leadership across business, finance, and accounting:  With Interest  INTHEBLACK  INTHEBLACK Out Loud  Excel Tips  Search for them in your podcast platform.  Email the podcast team at podcasts@cpaaustralia.com.au 

AML is seeking forgiveness after she realized she ruined her friends group text!

AML is seeking forgiveness after she realized she ruined her friends group text!

In this episode of This Week in AML, Elliot Berman and John Byrne unpack a pile of developments across the globe. From the EU's decision to add Russia to its AML blacklist and phase out Russian gas imports, to major enforcement action against a crypto mixer, the conversation dives deep into the evolving financial crime landscape. They also cover Canada's updated guidance on politically exposed persons, U.S. alerts on cross-border transfers, OCC's changes for community banks, and a surprising OFAC penalty tied to real estate sanctions. Plus, insights on humanitarian access challenges and upcoming year-in-review discussions. Stay informed on what's shaping compliance and risk management today.

The UK's anti-money laundering (AML) landscape is undergoing a significant transformation. The government has confirmed that the Financial Conduct Authority (FCA) will take over from the Solicitors Regulation Authority (SRA), the Law Society of Scotland, and other professional bodies to become the Single Professional Services Supervisor (SPSS) for AML supervision. This marks the first time law firms and accountancy firms across the UK will be regulated under a single AML authority. In this webinar recording, VinciWorks' legal compliance experts, alongside our partners at The Compliance Office and special guest Mike Ross, Director & MLRO at Anderson Strathern, break down the details of this major shift. We discuss what the government's consultation on the new structure entails, what questions remain unanswered, and the potential implications for firms across the UK, including specific insights into how Scottish firms might be affected. In this recording, you'll hear about: • The FCA's new role as the Single Professional Services Supervisor • Key insights from the consultation, including unanswered questions • A comparison of the FCA's and SRA's approaches to AML regulation • The views of Scottish firms and the Law Society of Scotland • What MLROs need to know and prepare for • The potential timeline for the transition This session is essential for compliance professionals, MLROs, and legal teams working in the UK's legal and accountancy sectors, providing critical insights into what the future of AML regulation will look like and how to prepare.

We hear from Emma Muldoon Ryan, Amlé and our panel of Tony McCormack, Fianna Fáil TD for Offaly, Gary Gannon, Social Democrat TD for Dublin Central, Donnchadh Ó'Laoghaire, Sinn Féin TD for Cork South Central and Claire Scott, Political Correspondent with the Sunday Times.

As part of a visit to Georgia Cancer Center in Augusta, Georgia, CancerNetwork spoke with a variety of experts and faculty members regarding ongoing research and future initiatives dedicated to improving outcomes across different patient populations. These conversations touched upon potential developments in diseases including non–small cell lung cancer (NSCLC), multiple myeloma, and acute myeloid leukemia (AML). First, Girindra Raval, MD, an associate professor in the Department of Medicine: Hematology and Oncology of the Medical College of Georgia at Augusta University, discussed current studies at his institution that may help optimize treatment for patients with lung cancer. This research ranged from retrospective trials analyzing how demographic features may influence outcomes to biomarker-based assessments intended to augment the efficacy of immunotherapy. Looking towards the future, Raval stated that determining how to sequence and de-escalate treatment amidst several available therapeutic options will be a key concern in the field. Additionally, Amany Keruakous, MD, director of Myeloma Research at Georgia Cancer Center and assistant professor in the Department of Medicine: Hematology and Oncology at the Medical College of Georgia of Augusta University, detailed strategies for mitigating current challenges in multiple myeloma care. She emphasized fostering collaborative relationships between colleagues in community settings and academic institutions to help reduce barriers to treatment access among patients. Furthermore, she noted the importance of conducting additional clinical trials at community centers.  Finally, Daniel Peters, MD, an assistant professor at the Medical College of Georgia at Augusta University and bone marrow transplant & cellular therapy faculty member at Georgia Cancer Center, focused on key developments across the AML space. At his institution, Peters and colleagues are evaluating potential drivers of immune dysfunction, which may inform less intensive cellular therapy approaches or determine who is suitable to receive autologous types of treatment. Peters also discussed how additional research set for presentation at meetings like the 2025 American Society of Hematology Annual Meeting and Exposition (ASH) may affirm a shift away from 7+3 intensive chemotherapy for patients who are younger and fit with newly diagnosed AML. 

In this special Thanksgiving edition of This Week in AML, Elliot Berman and John Byrne break from tradition to spotlight the Financial Action Task Force (FATF) and its three 2025 plenaries. They explore key developments, including updates to FATF standards, mutual evaluations, financial inclusion initiatives, and the evolving global stance on virtual assets. The episode also covers jurisdictional changes in monitoring status, new guidance on asset recovery, and FATF's forward-looking Horizon Scan addressing emerging tech threats like generative AI and deepfakes. Tune in for a comprehensive overview of FATF's strategic direction and its impact on the global AML landscape.

Why do the best grapes come from the most difficult soil? In this episode, we explore the concept of "struggle" with Drew Baker, co-founder of Burnt Hill Farm. Drew explains why he specifically chose the rocky terrain of Clarksburg, Maryland, to launch his exclusive, high-end wine label, supported by the infrastructure of his family's Old Westminster Winery.But the struggle isn't limited to the vines. Drew shares his incredible story of survival against acute myeloid leukemia (AML). After facing a grim prognosis and undergoing experimental treatments, including two bone marrow transplants donated by his sisters, Drew is here to share his story. Join us for a powerful look at how resilience, both in the vineyard and in the hospital, has shaped Drew's life and created a profound sense of pride in what he and his sisters have built together.Subscribe to our YouTube ChannelFollow Chris on Instagram Like us on Facebook! Supported by the Brewers Association of Maryland‍ ‍

In this episode of AML Conversations, Joe McNamara speaks with David Lutz, Associate Director of the AML RightSource Financial Crime Advisory group about the evolving Crypto landscape, recent milestones in the space, and how recent legislation has opened the door to further legitimacy and regulation. The cryptocurrency industry is experiencing its fintech moment - trading the freedom of the Wild West for legitimacy in the regulated financial system. With the GENIUS Act establishing the first federal framework for stablecoins and new EU travel rule requirements taking effect in 2026, crypto exchanges must now meet higher AML standards that align with the expectations of traditional banking partners.

An AML thinks his wife is cheating based on something he saw on Apple Car Play!

Discover why AML and fraud prevention must converge to tackle modern threats effectively. In this episode of the Risk Management Show, Boris Agranovich, founder and CEO of Global Risk Community, interviews Nauman Abuzar, Director of AML and Risk Solutions at SEON, to explore how shared data, dynamic customer behavior analysis, and AI-driven solutions are reshaping compliance and fraud detection. With over a decade of experience in compliance, financial crime, and fraud prevention across fintech, regtech, crypto, and payments, Nauman shares invaluable insights on designing robust risk frameworks, addressing regulatory challenges, and adopting advanced technologies like real-time transaction monitoring and machine learning. We discussed the growth of stablecoins, evolving regulatory expectations, and why retrospective alerting is no longer sufficient. Nauman emphasizes the importance of shared consortium data, holistic customer views, and co-designing compliance technology to meet global and local regulatory demands. This episode is packed with actionable insights for Chief Risk Officers, cybersecurity professionals, and anyone involved in AML and fraud prevention. Check out Risk Tools for Flexible Analysis https://seon.io/editions/flexible-analysis/ (Execute risk-based workflows at scale, and with ease, through custom AML screening, regulatory rule organization and clear insight into alert trends.) If you want to be our guest or suggest a guest, send your email to info@globalriskconsult.com with the subject line "Podcast Guest."

October 2025 shook the crypto world. Bitcoin crashed harder than any October since 2015, someone accidentally minted $300 trillion in stablecoins, and traditional banks started an all-out war against crypto companies trying to get federal charters. Tedd Huff, founder of Fintech Confidential and CEO of fintech advisory firm Voalyre, sits down with Rob Musiala, partner at Baker Hostetler who co-leads The Blockchain Monitor, to break down what moved Web3 when it mattered most. They walk through why stablecoins just crushed major card networks with $2.6 trillion in annual volume, how Western Union suddenly decided blockchain payments make sense, and what the Genius Act really means for everyone trying to operate in this space. This isn't theory. Banks are fighting to protect their turf while crypto infrastructure gets bought up for billions. The conversation covers enforcement crackdowns, court rulings that actually matter, regulatory battles over OCC charters, and why sitting this one out stopped being an option months ago. KEY TAKEAWAYS 1️⃣ Financial institutions must evaluate make-or-buy decisions on stablecoin infrastructure before competitors capture market share as platforms offering blockchain-based payments already process volumes exceeding major card networks. 2️⃣ Developers building on Ethereum layer-2 solutions can expect 30-60% lower transaction fees after Fusaka activates December 3rd, allowing projects to adjust pricing models or capture improved margins. 3️⃣ Stablecoin issuers, custodians, payment facilitators, and exchanges face different compliance requirements based on their specific business models under the Genius Act framework. 4️⃣ Retail investors and traders experienced 60-80% losses across major meme coins during October, while newcomers like Mini U and MemeCore surged during the same downturn. 5️⃣ Businesses operating cross-border payments between Japan and international markets gain new infrastructure as institutions push toward 10 trillion yen stablecoin circulation targets. LINKS Host:Tedd Huff (LinkedIn) - https://www.linkedin.com/in/teddhuff/Voalyre - https://voalyre.com CI (Confidential Informant):Rob Musiala (LinkedIn) - https://www.linkedin.com/in/robertmusiala/The Blockchain Monitor - https://www.theblockchainmonitor.com Company:Baker Hostetler - https://www.bakerlaw.com Fintech Confidential:YouTube - https://www.youtube.com/@FintechConfidentialWebsite - https://fintechconfidential.comNewsletter - https://fintechconfidential.com/newsletterLinkedIn - https://www.linkedin.com/company/fintech-confidential SUPPORTERS Dfns - Secure wallets built right. API-first, multi-chain MPC wallet infrastructure for payments platforms, custodians, and exchanges. Request demo: fintechconfidential.com/dfns Skyflow - Build fast without breaking privacy. Zero trust data privacy vault delivered as an API for PCI, GDPR, and SOC 2 compliance. Learn more: skyflowsecure.com Hawk AI - Fight fraud and financial crime with real-time payment screening, AML transaction monitoring, and dynamic customer risk rating. Sign up for demo: GetHawkAI.comAbout:GuestConfidential Informant - Robert Musiala - Partner - BakerHostetlerRobert Musiala has been working in the blockchain and digital assets market since 2012 and has led multiple digital asset investigations, including as the court appointed receiver over cryptocurrency investment funds used in a major fraud. Robert also advises on a variety of regulatory compliance issues involving digital assets and has drafted/negotiated agreements for a wide range of transactions...

In this episode of The Smart Property Investment Show, host Phil Tarrant is joined by Costa Arvanitopoulos from Finni Mortgages to unpack Macquarie Bank's retreat from trust and company lending and the rising role of self-managed super funds (SMSFs) in property investment. They explain that Macquarie's move, driven by tighter anti-money laundering (AML) scrutiny and concerns over spruikers using trusts to dodge serviceability rules, signals a broader shift in how lenders view complex structures. While this may disrupt investors who use trusts for tax and asset protection, borrowing in personal names remains available, and other lenders are expected to fill the gap. Against this backdrop, Tarrant and Arvanitopoulos highlight SMSFs as a more mainstream and increasingly popular vehicle for property investment. Arvanitopoulos notes that SMSFs let investors use their super to buy property without impacting personal borrowing capacity, which is particularly useful for those already maxed out in their own names. He explains that SMSF lending focuses on fund contributions, rental income and, for business owners, company financials to prove serviceability. The duo also flag the limitations and tax settings around SMSFs, including no equity release, no major renovations, and higher tax rates on very large balances. If you like this episode, show your support by rating us or leaving a review on Apple Podcasts and by following Smart Property Investment on social media: Facebook, X (formerly Twitter) and LinkedIn. If you would like to get in touch with our team, email editor@smartpropertyinvestment.com.au for more insights, or hear your voice on the show by recording a question below.

In this episode of This Week in AML, Elliot Berman and John Byrne cover a wide range of pressing financial crime topics. They discuss FATF's latest report on combating online child exploitation, the UK's Economic Crime Survey findings on sanctions awareness and fraud, and updates from FinCEN on cartel-linked gambling establishments. Other highlights include enforcement actions against elder fraud, tariff evasion prosecutions, and regulatory changes at the Federal Reserve. Tune in for expert analysis and actionable insights for compliance professionals.

Welcome to OncLive On Air®! OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today's episode, we had the pleasure of speaking with Harry P. Erba, MD, PhD, about the FDA approval of ziftomenib (Komzifti) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation who have no satisfactory alternative treatment options. Dr Erba is a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine at the Duke University School of Medicine, as well as director of the Leukemia Program and director of Phase I Development in Hematologic Malignancies. He is also a member of the Duke Cancer Institute in Durham, North Carolina. In our exclusive interview, Dr Erba discussed the significance of this approval, key efficacy and safety findings from the pivotal phase 1/2 KOMET-001 trial (NCT04067336), and the role ziftomenib may play throughout the evolution of the AML treatment paradigm. _____ That's all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field. For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters. OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn. If you liked today's episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us! Thanks again for listening to OncLive On Air. *OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn. This content is a production of OncLive; this OncLive On Air podcast is supported by funding, however, content is produced and independently developed by OncLive.

Buying a home or thinking about refinancing? Talk to Gregg Shaft with Barrett Financial Group. He makes the process smooth, fast, and stress-free. http://barrettfinancial.com/gshaft Want more MTM Vegas? Check out our Patreon for access to our exclusive weekly aftershow! patreon.com/mtmvegas Want to work with us? Reach out! inquiries at mtmvegas dot com Episode Description This week Caesars Entertainment agreed to pay a $7.8 million fine in relation to a famous bookmaker gambling in their casinos. While the company does not admit fault, in the proposed settlement they will pay huge money and tighten up AML procedures, but is this enough? Does this latest fine expose the culture of turning the other way in Nevada's casinos? In other news Stage Door Casino has reopened after months of rehab. It doesn't look too different, but that isn't necessarily a bad thing. We also discuss: MGM's holiday festivities, MGM Grand's finished renovation, Guy Fieri's higher prices, Red Rock's new pizza, Todd English losing a restaurant, TX BBQ coming to Vegas, a Downtown social media feud, more leaks and Landmark vs. Stratosphere 1995. Episode Guide 0:00 Landmark vs. Stratosphere 1995 0:37 Rain, leaks and incredible photos in Vegas 1:39 MGM's holiday celebrations - Drink specials, shows & more 3:13 MGM Grand completes $300 million room remodel 5:54 Binion's social media fights back 6:55 Westgate suite with a pianist? 8:17 Girlfriend wiped out the Vegas minibar! 9:42 Lake Mead is heading toward all-time low 10:38 Hard Rock Tejon now open - Peak at Vegas future? 12:22 Guitar Tower Christmas coming to Vegas? 13:33 Todd English Pepper Club closing 14:22 Real Texas BBQ coming to Fontainebleau popup 15:25 Guy Fieri raises the price of his $20 brunch 16:04 Stage Door Casino now reopen 16:50 Good Pie expanding - New home at Red Rock 18:38 Caesars' $7.8 million fine - Huge mistakes! 19:59 How Matthew Boyer's gambling has taken down Vegas casinos Each week tens of thousands of people tune into our MtM Vegas news shows at http://www.YouTube.com/milestomemories. We do two news shows weekly on YouTube with this being the audio version. Never miss out on the latest happenings in and around Las Vegas! Enjoying the podcast? Please consider leaving us a positive review on your favorite podcast platform! You can also connect with us anytime at podcast@milestomemories.com.  You can subscribe on Apple Podcasts, Google Podcasts, Spotify or by searching "MtM Vegas" or "Miles to Memories" in your favorite podcast app. Don't forget to check out our travel/miles/points podcast as well!

Today, we have a special episode correlated with Fraud awareness week, and brought to you by our friends at SEON - the command center for fraud prevention and AML compliance. SEON connects first party data signals to show you what other solutions can't - by enriching data, understanding context, and taking action from one place... to prevent fraud.In this episode, we are talking with Husnain "HB" Bajwa, SVP of Product & Risk Solutions. He has been a fraud and risk leader for 30+ years, and leads innovation in fraud prevention and compliance at SEON. HB is going to touch on important topics in the fraud detection and prevention space, such as AI, regulatory pressures, and the perspectives of startups that can get them into trouble.Questions:You've spent a lot of time in the world of fraud and compliance. What first drew you to solving these kinds of problems?Startups often focus on growth first and worry about fraud later. What's the hidden risk in that mindset?Why do you believe fraud prevention and AML compliance are converging, and what are the benefits of them living in the same system?AI gets talked about a lot, but in your view, what are the real, practical ways it's improving fraud and AML work today?We're seeing more regulatory pressure globally. How can organizations prepare for 2026 to ensure they are taking a risk-based approach to compliance?I know your team's been working on some big innovations, including a new compliance suite built on top of your fraud prevention stack and new AI-driven tools. How are these helping investigators connect the dots faster and uncover hidden relationships, especially when it comes to complex cases?What advice would you give to early-stage startups that might think they're ‘too small' to be targeted by fraudsters?Linkshttps://seon.io/https://www.linkedin.com/in/hbajwa/Our Sponsors:* Check out Incogni: https://incogni.com/codestory* Check out NordVPN: https://nordprotect.com/codestorySupport this podcast at — https://redcircle.com/code-story-insights-from-startup-tech-leaders/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of the Oncology Brothers podcast, we dived into the exciting world of cancer treatment with a focus on the recent FDA approval of Ziftomenib for relapsed refractory NPM1 mutated acute myeloid leukemia (AML).  We were joined by Dr. Eunice Wang from Roswell Park Comprehensive Cancer Center as our guest. Dr. Wang shared insights from the KOMET-001 study, detailing the study design, efficacy, and safety profile of Ziftomenib. With a response rate of nearly 30% and significant overall survival benefits for patients, this new treatment option is a promising step forward in managing heavily pretreated AML. Key topics covered in this episode included: The mechanism of action of Ziftomenib as a menin inhibitor Study findings from KOMET-001 and patient response rates Management of side effects, including differentiation syndrome and QTc prolongation Comparison with other menin inhibitors like Revumenib Future directions for combination therapies and sequencing of treatments Whether you're a healthcare professional, a patient, or simply interested in the latest advancements in cancer therapy, this episode is packed with valuable information.  Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Don't forget to like, subscribe, and check out our other episodes for more insights into FDA approvals, toxicity management, and practice-changing conference highlights. #Ziftomenib #MeninInhibitor #AML #NPM1 #Leukemia #FDAapproval #OncologyBrothers

Send us a textThe Executive director of the Alaska Municipal League is Nils Andreassen. The Alaska Municipal League (AML) is a nonprofit, nonpartisan, statewide membership organization of 165 cities, boroughs, and unified municipalities, representing over 97 percent of Alaska's residents. Originally organized in 1950, the League of Alaskan Cities became the Alaska Municipal League in 1962 when boroughs joined the League. Nils grew up in Washington State, earned a degree in Peace and Development studies from the University of Bradford in Great Britain, and served as the executive director of the Institute of the North prior to moving to AML in 2018.

In this episode of This Week in AML, Elliot Berman and John Byrne dive into a wide range of developments shaping financial crime compliance worldwide. From controversial U.S. pardons and their implications for corruption cases, to Australia's staggering $82 billion organized crime costs, and the UK's new anti-fraud campaign targeting crypto scams—there's plenty to unpack. The discussion also covers the Bank of England's stablecoin limits, the latest Global Organized Crime Index findings, intelligence-sharing breakdowns between allies, major sanctions relief for Syria, and a record AML fine against JP Morgan in Germany.

Keith Raphael, Found and CEO of Straddle in this episode talks about compliance requirements for organizations that move money. We go over the specific examples and go in-depth into each scenario that triggers specific compliance requirements.Key takeaways from the episode:Reg E only applies to consumer transactionsReg Z is applied to debt instruments belonging to the individual consumer.Reg E is applied any time the consumer account is debited electronically. Reg E is the safety net that makes consumers comfortable about the banking system. Specifically it offers proper protocols that forces everyone to abide by.Reg E forces the FI or a payment processor or a marketplace owner - whoever is interacting directly with the customer, has to cover the transactions that are claimed as fraudulent by the consumer while they are under the investigation by the bank."You can't be too small for the AML rules". Whoever you are and whatever your intentions are, if you participate in the money laundering of any form (even if unintentionally), you will be punished.If an entity is acting as an agent of the payee, they don't have to adhere to the same regulations as an MSB. FinCEN Payment processor exemption allows some money flows to not be considered as Money Transmitters.The moment we are talking about storing value for an individual, processing P2P transactions - think MTL requirements.Article on FBO accounts issued through Omnibus accounts through sponsor banks: https://open.substack.com/pub/aftfinance/p/what-are-omnibus-accounts?r=8gvix&utm_campaign=post&utm_medium=web&showWelcomeOnShare=falseCDD = Customer Due Diligence My favorite quote from Keith: "If you solve for identity in payments, everything else is just accounting".And here is the article that I recently wrote on the subject of KYC/KYB requirements: https://aftfinance.substack.com/p/kyc-kyb-aml-and-bsa?r=8gvix

Watch The X22 Report On Video No videos found (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:17532056201798502,size:[0, 0],id:"ld-9437-3289"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="https://cdn2.decide.dev/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");pt> Click On Picture To See Larger PictureThe EU and other countries are heading in the opposite direction of the US. They are moving towards a CBDC and total control of their population. The US is going to break free from the [CB] enslavement. Trump will be returning the buying power back to the people and its going to shock everyone. The D's just admitted that they were responsible for the shutdown, they received nothing and made the people suffer. Did Trump and team shutdown private flights to keep the [DS] players in this country? Trump pardons the electors and those who were investigating election fraud. Election rigging is about to be exposed to the world. Justice is coming.   Economy https://twitter.com/shanaka86/status/1987750485840031806?s=20 1. Cash Over €10,000 Becoming "Illegal Tender" in January 2027 What's true: Starting in summer 2027 (not precisely January), there will be an EU-wide limit on cash payments for goods and services: no more than €10,000 per transaction (or linked transactions). This applies across all 27 member states, though countries can set lower thresholds if they want (e.g., some already have limits around €1,000–€3,000). The goal is to curb illicit cash flows used for crime. What's false: Cash itself doesn't become "illegal tender"—you can still hold unlimited euros in cash, withdraw it from banks, or use it for smaller payments without issue. The restriction is only on using cash to pay for things above the limit (e.g., you couldn't buy a €15,000 car in cash without switching to wire transfer or card). Violators face fines or penalties, but it's not a blanket criminalization of cash holdings. This builds on existing rules but standardizes them EU-wide for the first time. 2. Every Bitcoin Needing "Government Permission" What's true: The rules ban anonymous crypto-asset accounts or wallets held through service providers (e.g., exchanges like Binance). Crypto firms must perform customer due diligence (CDD)—verifying identities—for any accounts they manage, similar to how banks already handle fiat accounts. Privacy-focused coins (e.g., Monero, Zcash) and unhosted (self-custodied) wallets face extra scrutiny if used for high-risk activities, and anonymous services will be prohibited. What's false: There's no requirement for "government permission" to own or transfer individual Bitcoins (or any crypto). You can still hold Bitcoin in a personal wallet, mine it, or peer-to-peer trade it without approval, as long as it's not through a regulated service that demands KYC (know-your-customer) checks. This ties into the broader Markets in Crypto-Assets (MiCA) regulation (effective 2024–2026), which licenses crypto platforms but doesn't micromanage personal holdings. The "permission" angle misrepresents standard AML checks, which apply to businesses handling crypto, not everyday users. 3. Every Transaction Becoming a "Datapoint in Brussels' Surveillance Grid" What's true: Financial institutions (banks, payment providers, crypto exchanges) must report suspicious transactions to national Financial Intelligence Units (FIUs), which share data via a new EU-level Anti-Money Laundering Authority (AMLA) based in Frankfurt (not Brussels). CDD kicks in for occasional transactions over €10,000, and high-risk activities (e.g., complex/large transfers) get extra monitoring. Records must be kept for 5 years. What's false: Not every transaction is tracked or reported—only suspicious ones, high-value occasional deals, or those flagged under risk-based rules. Everyday purchases (e.g.,